Veeva Systems Inc. has announced a new commitment from Gilead Sciences to adopt Veeva Vault CRM. This next-generation CRM system offers advanced capabilities, including agentic AI features designed to enhance commercial execution. Peter Gassner, CEO of Veeva, expressed honor in extending their strategic partnership with Gilead, a leader in innovative medicines for virology, inflammation, and oncology. Anna Åsberg, global CIO at Gilead Sciences, highlighted the shared commitment to advancing medicine and the potential of Veeva AI to elevate their commercial operations. The Vault CRM is part of Veeva's comprehensive suite of applications aimed at improving commercial efficiency and effectiveness through AI-driven tools.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Veeva Systems Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: SF70250) on September 10, 2025, and is solely responsible for the information contained therein.